The amniotic fluid taken from pregnant women during amniocentesis could provide doctors with cells to correct birth defects and researchers with a new non-controversial source of fetal stem cells, say researchers from Harvard Medical School. Dr Amir Kaviani and colleagues found that cells harvested from amniotic fluid might have the potential to be engineered into tissues to correct certain birth defects. Using just 2 milliliters of amniotic fluid, the researchers managed to grow 20,000 new cells – 80% of which were found to be viable. The findings suggest that amniotic fluid could be frozen, in order to supply a person with engineered tissue at any age, should they need it. The team also believe that amniotic fluid will be a good source of stem cells.
SOURCE/REFERENCE: Reported by www.reutershealth.com on the 11th October 2001
